Arbutus Biopharma Corp·4

Dec 16, 4:33 PM ET

McElhaugh Michael J. 4

4 · Arbutus Biopharma Corp · Filed Dec 16, 2020

Insider Transaction Report

Form 4
Period: 2020-12-14
McElhaugh Michael J.
DirectorInterim President & CEO
Transactions
  • Sale

    Common Stock

    2020-12-14$5.00/sh10,000$50,0321,327,457 total
  • Sale

    Common Stock

    2020-12-14$5.00/sh30,000$150,0001,337,457 total
Footnotes (1)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020.

Documents

2 files